拜师学艺
Lv11
70 积分
2022-08-18 加入
-
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial
3个月前
已完结
-
Sintilimab combined with apatinib plus capecitabine in the treatment of unresectable hepatocellular carcinoma: A prospective, open-label, single-arm, phase II clinical study
3个月前
已关闭
-
Capecitabine in advanced hepatocellular carcinoma: A multicenter experience
3个月前
已关闭
-
Surveillance for hepatocellular carcinoma: current status and future perspectives for improvement
5个月前
已完结
-
Is liver regeneration key in hepatocellular carcinoma development?
5个月前
已完结
-
Biomarkers for immunotherapy of hepatocellular carcinoma
5个月前
已完结
-
Human liver cancer organoids: Biological applications, current challenges, and prospects in hepatoma therapy
5个月前
已完结
-
Hepatocellular carcinoma
5个月前
已完结
-
Neoadjuvant Pyrotinib plus Trastuzumab, Docetaxel, and Carboplatin in Early or Locally Advanced Human Epidermal Receptor 2-Positive Breast Cancer in China: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
5个月前
已完结
-
ROCKET: Phase II Randomized, Active-controlled, Multicenter Trial to Assess the Safety and Efficacy of RRx-001 + Irinotecan vs. Single-agent Regorafenib in Third/Fourth Line Colorectal Cancer
6个月前
已完结